MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4Shaoshui Chen(Binzhou Medical University)Diagnostic PathologyJuly 10, 201410.1186/1746-1596-9-143Cited by 76SaveCiteExport RISWatch citationsRelated PapersComparison of efficacy and safety of ripertamab (SCT400) versus rituximab (Mabthera <sup>®</sup> ) in combination with CHOP in patients with previously untreated CD20‐positive diffuse large B‐cell lymphoma: A randomized, single‐blind, phase III clinical trial|Hematological Oncology|2022|9